IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

521.97 +3.58 (+0.69%)

Delayed Quote Updated: 11:27 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

IDEXX Laboratories to Release 2023 First Quarter Financial Results

April 13, 2023

From IDEXX Laboratories, Inc.

Via Business Wire

What Does IDEXX Laboratories' Debt Look Like? ↗

April 11, 2023

Via Benzinga

$100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today ↗

March 31, 2023

Via Benzinga

Analyst Expectations for IDEXX Laboratories's Future ↗

March 23, 2023

Via Benzinga

$1000 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today ↗

March 15, 2023

Via Benzinga

What Does IDEXX Laboratories' Debt Look Like? ↗

March 13, 2023

Via Benzinga

A Look Into IDEXX Laboratories' Debt ↗

March 06, 2023

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today ↗

March 02, 2023

Via Benzinga

2 Top Healthcare Stocks to Buy Right Now ↗

February 13, 2023

One has a breakout drug, the other a nice-sized moat.

Via The Motley Fool

Where IDEXX Laboratories Stands With Analysts ↗

February 08, 2023

Via Benzinga

Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead

February 16, 2023

Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.

Via MarketBeat

2 Top Stocks I'm Buying Hand Over Fist in February ↗

February 10, 2023

Despite underwhelming earnings reports, these businesses remain great investments in 2023.

Via The Motley Fool

Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today ↗

February 07, 2023

Via Benzinga

Analyst Says IDEXX Laboratories' Long-Term Growth Outlook Remains Strong ↗

February 06, 2023

Via Benzinga

Five Best And Worst Performing Healthcare Stocks In January 2023 ↗

February 05, 2023

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and...

Via Talk Markets

A Preview Of IDEXX Laboratories's Earnings ↗

February 03, 2023

Via Benzinga

Golden Cross Appears Before IDEXX Laboratories Investors ↗

December 27, 2022

Via Benzinga

Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know ↗

November 15, 2022

Via Benzinga

Earnings Scheduled For February 6, 2023 ↗

February 06, 2023

Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion.

Via Benzinga

Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

January 23, 2023

On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier.

Via Investor's Business Daily

Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge ↗

January 23, 2023

The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.

Via Investor's Business Daily

InMode Stock Glowing Again As Cosmetic Surgery Market Recovers ↗

January 23, 2023

The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.

Via Investor's Business Daily

IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

January 09, 2023

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

GE HealthCare Technologies Soars As GE Legacy Business Plummets

January 05, 2023

Wednesday marked the trading debut of GE HealthCare Technologies, the health-focused business spun off from General Electric. Shares rose 12%.

Via MarketBeat

Topics Stocks

What Does IDEXX Laboratories' Debt Look Like? ↗

January 04, 2023

Shares of IDEXX Laboratories Inc. (NASDAQ:IDXX) moved higher by 28.56% in the past three months. Before having a look at the importance of debt, let's look at how much debt IDEXX Laboratories has.

Via Benzinga

3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023 ↗

December 26, 2022

By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her.

Via The Motley Fool

Looking Into IDEXX Laboratories's Return On Capital Employed ↗

November 08, 2022

Pulled from Benzinga Pro data, IDEXX Laboratories (NASDAQ:IDXX) posted Q3 earnings of $180.94 million, an increase from Q2 of 37.1%. Sales dropped to $841.66 million, a 2.19% decrease between...

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗

November 02, 2022

U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.